Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Calcium channel blocker.
Dihydropyrazine found in Ligusticum walliichi. ...
GABA-A agonist, NMDA antagonist, voltage-gated ...
Mycotoxin.
Epoxomicin analog; proteasome inhibitor.
Docetaxel impurity
Nucleoside (guanosine) analog; DNA chain termin...
PDK1 and Akt inhibitor.
Tropane alkaloid found in Solanaceae plants; M1...
Nicotinic acid derivative; InhA inhibitor.
Tropane alkaloid found in plants in the Solanac...
Cyclic peptide; calcineurin inhibitor.
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
NSAID; COX-1/2 inhibitor.
O-methylated coumarin; Ca2+ channel blocker.
Degrades of BET proteins.
Synthetic progestogen, orexigenic.
Impurity of everolimus
L-type Ca2+ channel blocker.
Polyene macrolide; ergosterol inhibitor.